EPO: Reference Overview and Reconstitution Notes

EPO (erythropoietin) is a protein hormone that tells the body to make more red blood cells. It belongs to a group called erythropoiesis-stimulating agents (ESAs), meaning substances that trigger red blood cell production. It is also an FDA-approved prescription biologic (a drug made from living cells) and is permanently banned in sport by WADA.

EPO

What it is

EPO, short for erythropoietin, is a natural hormone made mainly by the kidneys. A hormone is a chemical signal the body produces to send instructions to other parts of the body. EPO is a glycoprotein hormone, meaning it is a protein with sugar molecules attached. Think of it like a key that fits one specific lock. EPO is the key, and the red blood cell factories in the bone marrow (the soft tissue inside bones where blood cells are made) have the matching lock.

EPO is the original molecule behind the drug group known as erythropoiesis-stimulating agents (ESAs). Erythropoiesis simply means "making red blood cells." Lab-made copies called recombinant products, such as epoetin alfa, belong to this group.

This is a neutral reference entry describing EPO's identity, regulatory status, and general handling.

Research context and categorization

Clinical Classification

EPO is classed as a hematopoietic growth factor, also called an erythropoiesis-stimulating agent. In plain terms, it is a signaling molecule that tells the bone marrow to produce more red blood cells.

In approved medical use, EPO is discussed in the context of anemia (a condition where the blood does not carry enough oxygen). Researchers study it for its ability to stimulate red blood cell production and improve how much oxygen the blood can carry.

Key point: Recombinant EPO is FDA-approved for specific types of anemia. Its possible tissue-protective and neuroprotective effects (meaning it may help protect body tissues and nerve cells) are still strictly investigational and have not been confirmed or approved.

Approved and Investigational Uses

Because EPO is an FDA-approved biologic, some of its uses are well established rather than speculative. Approved uses include anemia linked to chronic kidney disease (long-term kidney damage) and anemia in certain patients receiving chemotherapy (cancer-fighting drugs).

Researchers have also studied EPO for possible tissue-protective and neuroprotective effects beyond its role in blood cell production. Those broader uses are still investigational and are not confirmed or approved benefits.

Status

• Regulatory status: FDA-approved. Recombinant human erythropoietin (a lab-made copy of the natural hormone) is sold as prescription biologic products. Examples include epoetin alfa, sold under brand names such as Epogen, Procrit, and the biosimilar (a near-identical copy of an approved biologic) Retacrit. Approved uses include anemia from chronic kidney disease and anemia in certain chemotherapy patients. It requires a prescription and is not sold over the counter.
• Sport status: Prohibited under the WADA Prohibited List. Erythropoietin and other similar receptor-activating substances fall under class S2 (peptide hormones, growth factors, and related substances). They are banned at all times, both in and out of competition.

Reconstitution notes (general)

For a lyophilized (freeze-dried) vial, the concentration you end up with is simply the amount in the vial divided by the volume of bacteriostatic water (water with a small preservative added) that you use.

Because EPO is typically measured in international units (IU) rather than milligrams, the same math applies as units per millilitre. Divide the labeled IU in the vial by the millilitres of bacteriostatic water added to get the concentration. The milligram version works the same way: milligrams in the vial divided by millilitres of water added. You can run the numbers with the calculator at peptide calculator.

Dilution and handling notes (compound-specific)

Liquid vs. Lyophilized Forms

There is an important distinction to know. Commercially manufactured, FDA-approved EPO drug products come as a ready-to-use sterile liquid solution, not as a powder that needs to be mixed.

Those pharmaceutical vials are clear and colorless. They are stored cold, kept in their box to protect from light, and should never be frozen or shaken. If the material you are working with is a genuine pharmaceutical ESA vial, there is no mixing step at all.

Reconstitution of Research-Grade Powder

A mixing step does apply to lyophilized research-grade vials that arrive as a freeze-dried powder. In that case, the key practical points are:

• Recombinant EPO is very potent even in tiny amounts. A typical specific activity (a measure of how active the compound is per unit of mass) falls in the range of roughly 100,000 to 150,000 IU per milligram. Because of this, research vials are usually labeled in IU and reach high unit concentrations even from a small volume of water.
• The volume of water added is usually small, around 1 millilitre of bacteriostatic water per vial, chosen so the final concentration is easy to measure. Adding more water makes a more dilute (weaker) solution that is easier to draw up. Adding less water makes it more concentrated.
• Add the water slowly, letting it run down the inner wall of the vial rather than aiming it straight at the powder.
• EPO is a fragile glycoprotein, so how you mix it matters. Swirl gently and do not shake. Shaking forces air into the liquid, creates foam, and can damage (denature, or unfold) the protein where air meets liquid. A slow, circular swirl for a few minutes, with occasional gentle tipping upside down and back, dissolves the powder without causing foam.
• The powder usually dissolves easily and produces a clear, colorless liquid. It should not gel or thicken. Any cloudiness, floating bits, or lasting foam after gentle mixing is a sign that the material has been stressed or has not fully dissolved.
• Protect the vial from prolonged light during and after mixing. This is consistent with how the manufactured liquid form is kept in its box away from light.

Handling and storage

To keep the compound stable, follow these storage guidelines:

• Refrigerate at 2 to 8 degrees Celsius and keep out of light.
• Do not freeze and do not shake.
• Wipe the rubber stopper with an alcohol swab before each puncture, and label the vial with the mixing (or first-use) date.
• A reconstituted vial preserved with bacteriostatic water is generally good for roughly four weeks in the refrigerator.
• Discard anything that has turned cloudy or discolored, or that shows floating particles.

Related reading

• Gonadorelin
• HCG
• HMG (Menotropins)
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is EPO and how does it work?

EPO (erythropoietin) is a glycoprotein hormone produced mainly by the kidneys that signals bone marrow to increase red blood cell production; recombinant versions (e.g., epoetin alfa) mimic this signaling action.

Is recombinant EPO FDA-approved and for what uses?

Yes. Recombinant human EPO is FDA-approved as a prescription biologic for anemia related to chronic kidney disease and certain chemotherapy patients. Broader tissue-protective uses remain strictly investigational.

How is concentration calculated when reconstituting a lyophilized EPO vial?

Divide the total amount in the vial by the volume of solvent added. For example, adding 1 mL to a vial yields a concentration equal to the full vial content per milliliter.

What the research community gets wrong about EPO handling

EPO is one of the more fragile proteins a bench worker will handle, and a few habits carried over from simpler peptides can quietly ruin a research sample. Here are the mix-ups we see most often.

• Treating it like an ordinary powder. EPO is a glycoprotein. It carries sugar chains and internal disulfide bonds that hold its folded shape. Shaking pushes the protein against the air and liquid boundary, where it can unfold and clump together. Swirl gently, do not shake, and let the water run down the inner wall of the vial instead of splashing onto the cake.
• Forgetting the carrier protein. Approved liquid EPO products list human albumin as an ingredient. Albumin works as a carrier protein that coats glass and plastic so the tiny amount of EPO does not stick to the container and get lost. Plain bacteriostatic water has no carrier, so a research solution can lose material to the walls, which matters more when very little protein is present.
• Assuming freeze and thaw is safe. The approved liquid product says never freeze it. Ice crystals and repeated freeze and thaw cycles stress the protein and can make it aggregate. Splitting a sample into single portions is kinder to it than freezing and thawing the same vial again and again.
• Ignoring cold and light. Approved EPO is kept at 2 to 8 degrees Celsius and shielded from light. Warm shelves and bright benches speed up breakdown, so keep the vial cold and in its box between uses.

From our bench: the thing we notice most with EPO is how readily it foams. When water is added straight onto the cake or the vial is tipped too quickly, a ring of bubbles forms and takes a long time to settle. Running the water slowly down the glass wall and swirling with an occasional gentle tip gives us a clear, colorless solution with far less foam, which matches what the protein handling references warn about air exposure.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. EPOGEN (epoetin alfa) prescribing label, FDA/DailyMed (human albumin as a formulation component; store at 2 to 8 degrees C; do not shake or freeze; protect from light)
5. Erythropoietin, EPO_HUMAN, UniProt entry P01588 (glycoprotein with N-linked and O-linked glycosylation and two disulfide bonds)
6. Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks, Am J Health-Syst Pharm 2003 (PubMed)